We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Genentech Files Suit Against Tanvex BioPharma for Alleged Infringement of Herceptin Patents
Genentech Files Suit Against Tanvex BioPharma for Alleged Infringement of Herceptin Patents
Roche subsidiary Genentech has filed a federal lawsuit claiming that Tanvex BioPharma’s not-yet-on-the-market biosimilar of Genentech’s blockbuster chemotherapy drug Herceptin infringes three patents.